State regulators determined the deal would not curb health insurance market competition, though New York is mandating the insurers still offer private Medicare products and avoid cutting benefits. The New York Department of Financial Services outlined the conditions in a letter to Aetna Monday.
Aetna now has 90 percent of required state approvals, an Aetna spokesperson told Bloomberg. New York’s conditional approval hinges on a sign-off from the U.S. Department of Justice.
Aetna met with top DOJ officials Friday to present the auction of its Medicare Advantage assets in hopes of pacifying antitrust concerns. The DOJ is currently reviewing the deal.
More articles on payer issues:
Conn. senator urges Cigna, Aetna to stay in state
Presbyterian Health Plan exits ACA exchange
Michigan insurers seek up to 39% premium rate increases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
